AbstractOBJECTIVESWe sought to evaluate the effects of spironolactone on neurohumoral factors and left ventricular remodeling in patients with congestive heart failure (CHF).BACKGROUNDAldosterone (ALD) promotes collagen synthesis and structural remodeling of the heart. Spironolactone, an ALD receptor antagonist, is reported to reduce mortality in patients with CHF, but its influence on left ventricular remodeling has not been clarified.METHODSThirty-seven patients with mild-to-moderate nonischemic CHF were randomly divided into two groups that received treatment with spironolactone (n = 20) or placebo (n = 17). We measured left ventricular volume and mass before treatment and after four months of treatment. We also measured the plasma level...
Background: Spironolactone is currently used in a large proportion of patients with heart failure ...
ObjectiveAlthough left ventricular restoration is effective for treating ischemic cardiomyopathy cau...
Aims To investigate the effects of spironolactone on fibrosis and cardiac function in people at incr...
AbstractOBJECTIVESWe sought to evaluate the effects of spironolactone on neurohumoral factors and le...
AbstractObjectivesWe sought to evaluate the effects of spironolactone on neurohormonal factors in pa...
OBJECTIVES: We sought to evaluate the effects of spironolactone on neurohormonal factors in patients...
AbstractOBJECTIVESThe study evaluated the transcardiac extraction or spillover of aldosterone (ALDO)...
Aims: Spironolactone improves prognosis in severe heart failure (HF). We investigated its effects in...
AbstractObjectivesWe sought to evaluate the effects of spironolactone on cardiac sympathetic nerve a...
SummaryBackgroundSpironolactone was shown to reduce mortality in patients with heart failure (HF). H...
Abstract The beneficial effects of spironolactone in chronic heart failure (HF) have been demonstra...
Aims: Spironolactone improves prognosis in severe heart failure (HF). We investigated its effects in...
ObjectivesThe objective of this study was to determine if adding spironolactone to an angiotensin II...
The purpose of our study was to assess the effects of a low dose of spironolactone in patients with ...
This study was designed to assess the effects of spironolactone (SP) on left ventricular (LV) functi...
Background: Spironolactone is currently used in a large proportion of patients with heart failure ...
ObjectiveAlthough left ventricular restoration is effective for treating ischemic cardiomyopathy cau...
Aims To investigate the effects of spironolactone on fibrosis and cardiac function in people at incr...
AbstractOBJECTIVESWe sought to evaluate the effects of spironolactone on neurohumoral factors and le...
AbstractObjectivesWe sought to evaluate the effects of spironolactone on neurohormonal factors in pa...
OBJECTIVES: We sought to evaluate the effects of spironolactone on neurohormonal factors in patients...
AbstractOBJECTIVESThe study evaluated the transcardiac extraction or spillover of aldosterone (ALDO)...
Aims: Spironolactone improves prognosis in severe heart failure (HF). We investigated its effects in...
AbstractObjectivesWe sought to evaluate the effects of spironolactone on cardiac sympathetic nerve a...
SummaryBackgroundSpironolactone was shown to reduce mortality in patients with heart failure (HF). H...
Abstract The beneficial effects of spironolactone in chronic heart failure (HF) have been demonstra...
Aims: Spironolactone improves prognosis in severe heart failure (HF). We investigated its effects in...
ObjectivesThe objective of this study was to determine if adding spironolactone to an angiotensin II...
The purpose of our study was to assess the effects of a low dose of spironolactone in patients with ...
This study was designed to assess the effects of spironolactone (SP) on left ventricular (LV) functi...
Background: Spironolactone is currently used in a large proportion of patients with heart failure ...
ObjectiveAlthough left ventricular restoration is effective for treating ischemic cardiomyopathy cau...
Aims To investigate the effects of spironolactone on fibrosis and cardiac function in people at incr...